Piramal Pharma Share Price

Piramal Pharma (INR)255.8437.8   (17.4%)

Exchange ScripsBSE543635NSEPPLPHARMAISININE0DK501011

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Piramal Pharma Performance

Market performance
Open price227.8
High259.9
Volumes95844092
Prev Close255.84
Low224.01
Closing date2024-10-24
Historical performance
1 Year High259.90
3 Year High259.90
5 Year High259.90
1 Year Low87.50
3 Year Low61.62
5 Year Low61.62

Piramal Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
0
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
1899.33
Dividend Yield
Dividend Yield
N/A

Piramal Pharma Investment Returns

1 Year
172.8%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Piramal Pharma Technicals

IndicatorsValueSignal
5-DMA228.49Bullish
10-DMA227.18Bullish
20-DMA225.74Bullish
50-DMA214.58Bullish
100-DMA187.44Bullish
200-DMA162.95Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1717171717
Foreign Investors---------------
Domestic Investors1717171717
Public Investors359734306381297979292295300589
Government11221

Piramal Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income2011225127581641
Operating Profit1371785331225515921
Interest4485344219821634
Depreciation7406676758625450
Profit Before Tax1793-120248509490
Consolidated Net Profit178-186537608350
Adjusted EPS----238

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1322911933118599946
Total Reserves65610558025510746103
Minority Interest------------
Total Non-Current Liabilities29288381202902625604
Total Liabilities152972144365127172107561
Capital Work in Progress5657852967323995
Total Assets152972144365127172107561

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities10045483976645976
Cash Flow from Investing Activities-4340-13388-18121-44799
Cash Flow from Financing Activitie-42248178794239768
Net Cash Inflow / Outflow1482-371-2515945
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 1899.33.
  • 3Y Stock Price CAGR of the stock is 17.4.
  • The stock has a beta of 0.5.
  • In the last financial year, the company had an EBITDA of ₹13717 Million.
  • The company generated revenue of ₹81712 Million in the previous financial year.

Piramal Pharma

255.8437.8   (17.4%)

Investment Amount: ₹ 9130
Current Value: ₹ 25584
Performence: 180.2%
P/L: ₹ 16454
Top Gainers
SymbolChange%
CARERATING1407(20%)
PPLPHARMA255.84(17%)
TARACHAND413.25(16%)
SONACOMS729.45(13%)
HIMATSEIDE166.75(11%)
Top Losers
SymbolChange%
KPITTECH1410.85(-14%)
LTFOODS352.2(-13%)
DIFFNKG396.64(-10%)
JCHAC2194.4(-10%)
HUHTAMAKI297.15(-9%)
ECOSMOBLTY393.1(-8%)
VIPIND471.65(-7%)
MITCON118.51(-7%)
Similar stocks

Unichem Lab

25.4

802.85

September 24 - October 24

Windlas Biotech

17.5

987.8

September 24 - October 24

RPG Life Sciences

15.6

2515.25

September 24 - October 24

Jagsonpal Pharma

15.1

477.75

September 24 - October 24

Gufic Biosciences

12

436.15

September 24 - October 24

Wockhardt

11.9

1121.45

September 24 - October 24

Strides Pharma Scien

10

1535.1

September 24 - October 24

Medicamen Biotech

7

481.05

September 24 - October 24

Announcing Stock of the Month!

Stock of the Month
Stock of the Month